Trillium Therapeutics Inc.
1 clinical trials · Sponsor
◉ Watch Trillium Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome (NCT01559961) | Trillium Therapeutics Inc. | 2012-03-01 |
Track Trillium Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.